高级搜索

盐酸托烷司琼、氟哌利多与PCA 伍用预防术中顺铂腹腔化疗后恶心呕吐的效果观察

Effect Observation of Combined Tropisetron, Droperidol and PCA to Prevent Nauseaing andVomiting During Operation Caused by IPC with Cisplatin

  • 摘要: 目的 对盐酸托烷司琼、氟哌利多与PCA伍用预防术中顺铂腹腔化疗后恶心呕吐的疗效进行观察。方法 选择44例ASAⅠ~Ⅱ级术中行顺铂腹腔化疗的患者,随机分为A组(试验组):盐酸托烷司琼5mg+氟哌利多2.5mg+芬太尼1.0mg;B组(对照组):氟哌利多5mg+芬太尼1.0mg。术毕均将顺铂100mg在缝合腹膜前注入腹腔内。A、B组分别静注盐酸托烷司琼5mg、生理盐水5ml后接PCA泵。结果 术后10小时内A组的优良率为95.5%.与B组68.2%、59.1%相比有显著差异(P<0.01、P<0.05)。术后10~36小时A组优良率较前10小时略下降为90.9%与B组63.6%仍有显著差异(P<0.05)。结论 盐酸托烷司琼、氟哌利多与PCA伍用在适量浓度下能较好的预防术中顺铂腹腔化疗后恶心呕吐。

     

    Abstract: Objective  To observe the curative effect with t ropiset ron, droperidol and PCA to prevent nausea and vomiting caused by IPC with cisplatin. Methods  44 cases of I~II grade ASA were used cisplatin to IPC during operation, and were divided into group A : t ropiset ron 5mg + droperidol 2. 5mg + fentyli 1. 0mg and group B (cont rol group) : droperidol 5mg + fentyli 1. 0mg randomly. Cisplatin was injected into abdominal cavity before suture. af ter t ropiset ron 5mg and saline solution were iv, PCA pump were linked to the patient s in these two groups. Results  The excellent rate of group A is 95. 5 % in 10 hours after operation, compare to the 68. 2 % and 59. 1 % of group B, there was a significant difference ( P <0. 01 、0. 05respectively) . During 10~36 hours af ter operation, the excellent rate of group A was declined to 90. 9 %, compare to the 63. 6 % of group B, there was also a significant difference ( P < 0. 05) . Conclusion  In the appropriate concent ration, combined hydrochloride tropiset ron, droperidol with PCA can preferable prevent nauseaing and vomiting during operation caused by IPC with cisplatin.

     

/

返回文章
返回